Trials / Completed
CompletedNCT03055676
Prospective Multicenter Trial of Early Versus Late Drain Removal After Pancreaticoduodenectomy
A Randomized Prospective Multicenter Trial of Early Versus Late Drain Removal After Pancreaticoduodenectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 319 (actual)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this randomized prospective multicenter study is to demonstrate the hypothesis that early removal of drain could reduce the incidence of major complications (grade 2-4) after pancreaticoduodenectomy (PD) , when compared with later removal of drain.
Detailed description
The objective of this randomized prospective multicenter study is to investigate the association between the time of removal of drain after pancreaticoduodenectomy (PD) and incidence of major complications (grade 2-4 complications). The investigators unite six pancreatic surgery center in Beijing. Patients who underwent pancreaticoduodenectomy (PD) or pylorus-preserving pancreaticoduodenectomy (PPPD) with low to moderate risk of post-operative pancreatic fistula (POPF) are recruited into the study. After obtaining informed consent, eligible patients are randomly allocated to early or late drain removal group on POD 3. In the group A, drain(s) are removed on POD 3, whereas in group B drain is removed on POD 5 or beyond. The primary outcomes are the incidence of sum of grade 2-4 complications, the secondary outcomes include grade B/C POPF, intra-abdominal infeciton, delayed gastric emptying, post-operative bleeding, in-hospital stay, total medical cost and comprehensive complication index (CCI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Early drain removal | Removing drain(s) on postoperative day 3 |
| OTHER | Late drain removal | Removing drain(s) on postoperative day 5 or later |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2020-03-01
- Completion
- 2020-04-01
- First posted
- 2017-02-16
- Last updated
- 2020-04-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03055676. Inclusion in this directory is not an endorsement.